COMMUNIQUÉS West-GlobeNewswire

Tetraphase Pharmaceuticals to Present XERAVA™ (Eravacycline) and TP-6076 Data at IDWeek 2018

19/09/2018 - 12:00

– Four Abstracts Selected for Poster Presentations – – TP-6076 Featured in Oral Presentation – WATERTOWN, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical [...]

Changes in responsibility areas of the Orion Group Executive Management Board

19/09/2018 - 10:46

ORION CORPORATION STOCK EXCHANGE RELEASE 19 SEPTEMBER 2018 at 11.45 a.m. EEST Changes in responsibility areas of the Orion Group Executive Management Board The following changes have been decided in responsibility areas [...]

APEIRON Announces Collaboration with Lead Discovery Center GmbH

19/09/2018 - 10:00

Alliance for medicinal chemistry optimization and development of novel checkpoint blockade approach VIENNA, Austria, Sept. 19, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, an Austrian company focused on cancer [...]

JSC Olainfarm attracts third Market Maker

19/09/2018 - 09:00

JSC Olainfarm announces that the Company has signed a Market Maker agreement with international investment company UAB “Orion Securities” thus joining few other Joint Stock companies in Baltics having three market [...]

LIDDS receives NanoZolid® technology patent protection until 2037

19/09/2018 - 08:30

The European Patent Office has approved a novel patent for LIDDS NanoZolid® technology. LIDDS patent protection for the drug delivery technology is now extended for at least another nineteen years. The new patent [...]

Solon Eiendom ASA – Primary insider notification

19/09/2018 - 08:30

(Oslo, Norway, September 18, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 20.000 shares in Solon Eiendom ASA at a price of NOK 29.017. Following [...]

Polydex Reports Second Quarter Financial Results

19/09/2018 - 08:12

Sales Remain Consistent, Profits Up TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) today announced financial results for the second quarter of the 2019 [...]

SPINEWAY : Souscription de 100 OCEANE

19/09/2018 - 08:01

Souscription de 100 obligations convertibles ou échangeables en actions nouvelles et/ou existantes (OCEANE) assorties de bons de souscription d'actions pour un montant nominal d'1 MEUR Spineway (la « Société ») annonce [...]

Rule 2.9 Announcement

19/09/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 19 September 2018 [...]

PCI Biotech: Commencement of subscription period

19/09/2018 - 07:50

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER [...]

Bavarian Nordic Delivers Smallpox Vaccine to England in Response to Current Monkeypox Cases

19/09/2018 - 07:31

English health authorities have ordered IMVANEX smallpox vaccine in response to monkeypox cases Immediate response ensured rapid delivery and deployment of vaccines COPENHAGEN, Denmark, September 19, 2018 - After the [...]

G1 Therapeutics Announces Pricing of Offering of Common Stock

19/09/2018 - 03:37

RESEARCH TRIANGLE PARK, N.C., Sept. 18, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced the pricing of an underwritten public offering of 3,000,000 [...]

argenx raises approximately $300.6 million in gross proceeds in a U.S. public offering

19/09/2018 - 02:46

Regulated information - Inside information September 18, 2018, 8:45 PM ET - September 19, 2018, 2:45 AM CEST Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology [...]

MediciNova to Present at the Ladenburg Thalmann 2018 Healthcare Conference in New York

19/09/2018 - 01:00

LA JOLLA, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]

Positive PEACHTREE Data to be Highlighted at EURETINA 2018

18/09/2018 - 22:30

ALPHARETTA, Ga., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

3-Year Clinical Outcomes and BPH Subgroup Analysis of Profound Medical’s Phase I Clinical Trial to be Included in Presentation at DGU 2018

18/09/2018 - 22:30

TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

Adverum to Present at Cantor Global Healthcare Conference

18/09/2018 - 22:10

MENLO PARK, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]

electroCore, Inc. to Present at the Cantor Global Healthcare Conference

18/09/2018 - 22:05

BASKING RIDGE, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced the company will be participating in the [...]

HealthEquity to Present at Investor Conference

18/09/2018 - 22:02

DRAPER, Utah, Sept. 18, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest independent health savings account (HSA) custodian, today announced that it plans to participate at the 2018 Cantor [...]